Rick D. Anderson - Jun 17, 2021 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Director
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 06:32 PM
Next filing
Jun 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +570 $0.00 570 Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Award $0 +4.07K $0.00 4.07K Jun 17, 2021 Common Stock 4.07K $50.40 Direct F2
transaction SILK Option (right to buy) Award $0 +2.83K $0.00 2.83K Jun 17, 2021 Common Stock 2.83K $50.40 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F2 All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
F3 The shares subject to the options represent cash retainer that the Reporting Person elected to receive in the form of stock options.
F4 One fourth of the shares subject to the option shall vest on each of September 5, 2021, December 5, 2021, March 5, 2022, and the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.